XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statement of Equity - USD ($)
Total
Common stock
Accumulated deficit
Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2022   14,366,616    
Beginning balance at Dec. 31, 2022 $ 35,974,006 $ 47,474,973 $ (11,208,841) $ (292,126)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Share-based compensation (in shares)   150,260    
Share-based compensation 90,156 $ 90,156    
Repurchase of common shares (in shares)   (86,829)    
Repurchase of common shares (187,961) $ (187,961)    
Net income (loss) 172,286   192,184 (19,898)
Ending balance (in shares) at Mar. 31, 2023   14,430,047    
Ending balance at Mar. 31, 2023 $ 36,048,487 $ 47,377,168 (11,016,657) (312,024)
Beginning balance (in shares) at Dec. 31, 2023 14,121,833 14,121,833    
Beginning balance at Dec. 31, 2023 $ 29,259,869 $ 47,091,602 (17,488,161) (343,572)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Share-based compensation (in shares)   163,991    
Share-based compensation 78,754 $ 78,754    
Repurchase of common shares (in shares)   (125,870)    
Repurchase of common shares (246,599) $ (246,599)    
Net income (loss) $ (1,902,472)   (1,946,263) 43,791
Ending balance (in shares) at Mar. 31, 2024 14,159,954 14,159,954    
Ending balance at Mar. 31, 2024 $ 27,189,552 $ 46,923,757 $ (19,434,424) $ (299,781)